Coronavirus Update: Pfizer Switches To Alternate COVID Vaccine Over T Cell Response
Plus: Yuhan and Abclon Advance Candidate
• By Scrip Team
Pfizer and BioNTech's Phase II/III study will be conducted across the US and countries such as Argetina, Brazil and Germany. • Source: Shutterstock 
